The authors said Paxlovid and molnupiravir ‘probably’ improve outcomes for outpatients with mild to moderate illness.
ACP issues updated Omicron-specific COVID-19 treatment guidance
More from COVID-19More posts in COVID-19 »
- Quick takes: School infection prevention, low US respiratory virus levels, polio in 3 nations
- Study: Kids with long COVID have impaired exercise capacity
- Global meta-analysis estimates 43% rate of multidrug resistance in COVID patients
- COVID-19 linked to increased preterm birth, other problems in pregnancy